PABLO DE LA
CUEVA DOBAO
Profesor asociado de Ciencias de la Salud
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari de Bellvitge (25)
2024
-
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study
Actas Dermo-Sifiliograficas
-
Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis
Actas Dermo-Sifiliograficas
2023
-
Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study
JEADV Clinical Practice, Vol. 2, Núm. 3, pp. 488-501
-
Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 10, pp. 865-883
-
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
Journal of Investigational Allergology and Clinical Immunology
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
2022
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project
Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31
-
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study
Dermatologic Therapy, Vol. 33, Núm. 6
2019
-
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis
Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 7, pp. 1214-1223
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
Journal of Dermatological Treatment, Vol. 30, Núm. 5, pp. 461-465
2018
-
Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 631-642
-
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain
Rheumatology International, Vol. 38, Núm. 6, pp. 1115-1124
2017
-
Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España
Reumatologia Clinica, Vol. 13, Núm. 2, pp. 85-90
-
Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians
Journal of Dermatological Treatment, Vol. 28, Núm. 3, pp. 188-199
-
Psoriasis moderada. Propuesta de definición
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 10, pp. 911-917
2016
-
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
Journal of Dermatological Treatment, Vol. 27, Núm. 3, pp. 203-209
-
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Actas dermo-sifiliograficas, Vol. 107, Núm. 3, pp. 194-206